Physician

John D Sprandio, M.D.

According to 2025 Medicare claims, John Sprandio, M.D. (NPI: 1144268913) practices hematology/oncology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is CONSULTANTS IN MEDICAL ONCOLOGY & HEMATOLOGY, PC (NPI: 1043265820; TIN: 23-2826618) and primary practice location at 19073-2304.

Sprandio's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 251 traditional Medicare patients, billed 134,057 HCPCS/CPT codes, and received $3,123,102 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,016 prescription claims across 158 beneficiaries totaling $2,295,011 in drug costs, led by Octagam (Immun Globg(Igg)/Malt/Iga Ov50). 2022 DME data shows 11 claims. Open Payments data shows 59 records totaling $2,816. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $448,707 to $3,123,102. Similarly, Part D prescription costs have moved sharply higher in recent years, from $153,023 to $2,295,011. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.